Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.
02/01/2008
L Carmona, JJ Gómez-Reino, V Rodríguez-Valverde, MD Montero, E Pascual-Gómez, E Martin Mola, L Carreño, M Figueroa, BIOBADASER Group.
Descargar documento
Arthritis Rheum 2005; 52(6):1766-72